Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: J Mol Cell Cardiol. 2016 Oct 13;100:109–117. doi: 10.1016/j.yjmcc.2016.10.005

Fig. 1.

Fig. 1

MMP-9 inhibitor (MMP-9i) treatment reduced MMP-9 activity early post-MI without affecting MMP-9 gene expression. (A) MMP-9 activity was reduced by 31 ± 1% in the inhibitor treated group, compared to saline MI. n = 10/group. (B) RT2-PCR analysis showed increased MMP-9 expression levels in both saline and MMP-9i LV infarct (LVI) compared to D0. n = 6/group. *p < 0.05 vs D0, #p < 0.05 vs saline.